Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients

This study has been terminated.
(could not enroll patients)
Bukwang Pharmaceutical
Information provided by:
Inje University Identifier:
First received: November 25, 2008
Last updated: June 22, 2011
Last verified: June 2011
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2010
  Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)